AKT1 and endometrial cancer: Reductions in m6A methylation induced by decreased METTL3 and mutation in METTL14 activate the phosphoinositide 3 kinase/protein kinase B (PI3K/AKT) pathway, promoting proliferation and tumorigenicity of endometrial cancer 18.